Cannabis Law Report

SEPTEMBER 9, 2021

WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHO: Jennifer Pelino, executive vice president, omnichannel media, IRI. . WHEN: Sept. 21, 2021, at 11:00 a.m.

Events 102

Events Wellness and Beauty Data Media 102

Cannabis Law Report

MARCH 7, 2020

hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.

Hemp 71

Hemp CBD Research and Development Safety 71

Cannabis Law Report

AUGUST 30, 2021

I’m excited to join the Travelers Institute for a data-driven discussion,” said Wasserman. With new census data, control of Congress on a knife-edge and redistricting just ahead, there couldn’t be a better time to dive into the numbers.”. Media: Sperry Mylott, 860.277.5075. 22 – “High Risk? smylott@travelers.com.

Programs 105

Programs Data Policy Topical 105

Cannabis Law Report

JUNE 16, 2021

If you feel like you’ve been catching a lot of Delta-8 THC content in the media lately, those aren’t just your social media apps hacking your brain. Hemp-derived Delta-8 THC is having a big moment in 2021 in terms of popularity and, most recently, in terms of concerns over legality, safety, and accuracy.

THC 117

THC Hemp Media Data 117

Cannabis Law Report

OCTOBER 22, 2021

–The Company expects to hold a Research & Development event to review,these breakthrough findings in Q4 2021 that will be open to the public, shareholders, analysts and the media– TORONTO, CANADA – October 19, 2021 – Cybin Inc.

Research and Development 52

Research and Development Safety Media Data 52

SpeedWeed

JULY 6, 2021

Safety data is limited, and testing for CRC contamination is missing—even in legalization states. Many legal and illicit hashmakers now use a ‘color remediation column’—often a steel cylinder (column) packed with a filtration media like sand—during extraction to filter impurities. What is CRC tech? How safe is CRC hash?

Hash 52

Hash Media Extraction Terpenes 52

Cannabis Law Report

JULY 8, 2021

The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safety data will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. and are difficult to predict. cbdMD, Inc. John Weston. Director of Investor Relations.

Research and Development 111

Research and Development Pets Cannabinoids eCommerce 111

Cannabis Law Report

MAY 6, 2022

The FDA explains it is monitoring the selling of CBD and Delta-8 THC products out of a growing safety concern. In short, the FDA has not evaluated or logged all dangerous side effects or safety concerns. Pre-clinical data support the possible use of CBD with Panic Disorder…Bipolar Disorder.”. Taking CBD can relieve pain.”. “In

THC 52

THC CBD Media Food 52

Cannabis Law Report

SEPTEMBER 15, 2021

The FDA is aware of media reports of delta-8 THC products getting consumers “high.” Thus, historical use of cannabis cannot be relied upon in establishing a level of safety for these products in humans. Findings based on NPDS data do not necessarily reflect the opinions of AAPCC. exposures to any substance(s).

THC 105

THC Pets Events Hemp 105

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. What if most of it is not based on the level of scientific certainty that cannabis marketing teams and media outlets would have us believe? Recent data suggest the US science knowledge is about the global average.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Canna Law Blog

APRIL 13, 2019

The letters were sent “in response to their making unsubstantiated claims related to more than a dozen different products and spanning multiple product webpages, online stores and social media websites.”

CBD 90

CBD Safety Topical Food 90

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. The Harris Poll is one of the longest running surveys in the U.S. To learn more, please visit www.theharrispoll.com.

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. In 2022, we anticipate reading out interim data from our ongoing Phase 2 clinical trial of GFB-887, as well as initial data from our ongoing Phase 1 study of GFB-024.

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

JUNE 20, 2022

The findings in this report point to policies and practices that promote and preserve public health and safety, while allowing legal businesses to compete.”. “We are pleased to release this report that highlights the successful launch of Maine’s adult use market,” said OCP Director Erik Gundersen. “The

Programs 52

Programs Policy Consumption Access 52

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. On track to report top-line data by end of 2021. Net loss for the six months ended 30 June 2021 was $30.2 million, or $0.79 million) compared with $24.8 million, or $2.61

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

The Blunt Truth

AUGUST 13, 2019

On May 31, 2019, the FDA’s Working Group held a public hearing for stakeholders to share their experiences and challenges with CBD products, including information and views related to product safety. The FDA is collecting data to fill these gaps. The public hearing attracted over 100 speakers and 2000 participants.

CBD 80

CBD Food Seed-To-Sale Wellness and Beauty 80

Cannabis Law Report

JULY 13, 2022

The 2022-23 budget and accompanying tax reform bill will provide significant and immediate relief to cannabis businesses, support equity operators, strengthen enforcement tools against illegal cannabis operators, and protect youth, environmental, and public safety programs funding. Supporting equity. million dollars to-date.

Compliance 52

Compliance Compliance Supply Chain Environment 52

Cannabis Law Report

DECEMBER 26, 2021

EBRX-101, a study that will evaluate the pharmacodynamics, pharmacokinetics and safety of a target controlled intravenous infusion of N, N-dimethyltryptamine (DMT) in a population of healthy smokers. For media inquiries, please contact Elizabeth Glassen of BlueSky Communications at: BlueSky Communications. Telephone: +1 (778) 919-8615.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Marijuana Lawyer Blog

DECEMBER 7, 2019

And as the epidemic dragged on, news reports covered a notable dip in vape sales, understandably as consumers took a slight step back from vaping until safety could be assured. Since then, data has shown that vaping cannabis sales have stabilized, and even increased market share in a number of states. the week of August 19 to 24.3%

Vaping 52

Vaping Safety Education Dispensary 52

Cannabis Law Report

OCTOBER 15, 2021

The presentation details the identification of a novel locus on chromosome 14 which is associated with proteinuric kidney disease and includes data which confirms the well-known association of APOL1 risk haplotypes (i.e., New data supporting the use of machine learning and electronic health records to predict DN in patients with diabetes. “In

Clinical Trials 52

Clinical Trials Research and Development Data Patients 52

Cannabis Law Report

NOVEMBER 22, 2019

. “MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking.” For media inquiries please contact: Michael Sharp. For more information visit: [link]. 561-627-9455. For Investment Opportunities: MFS Capital Advisors.

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

JUNE 16, 2021

Genetic Screening Platform Technology and Data to Strengthen Entheon’s Psychedelic-Assisted Protocols. Lobo brings a highly experienced and specialized team of technology experts in the fields of genetics, diagnostics, data and analytics, as well as a fully operational 5,000 sq. Vancouver, British Columbia–(Newsfile Corp.

Research and Development 105

Research and Development Data Conditions Events 105

WeedAdvisor

JULY 21, 2019

The Financial Times explains: “The excitement over cannabis in Colombia has reached fever pitch with some local media reports suggesting the country could supply two-fifths of the world’s marijuana and earn more from it than it does from coal or cut flowers. The checklist is endless, but every box needs to be marked.

Conditions 60

Conditions Seed-To-Sale Compliance Compliance 60

Cannabis Law Report

FEBRUARY 3, 2022

Health and Safety. The safety of our community is of utmost importance to ensure a constructive live event that advances the dynamic advanced design and manufacturing sectors that rely on IME West for new business partnerships and continued education.”. Media Contacts Lauren Lloyd. IMEWest #DiscoverEngineerBuild. PR Director.

Packaging 52

Packaging Events Education Supply Chain 52

WeedAdvisor

JULY 8, 2019

Media outlets like Marijuana Business Daily , however, obtained more information from CannTrust and offer a more complete picture. Ensuring product safety and availability is our priority.”. Eventually, CannTrust pledged to work with Health Canada in ensuring future compliance. The fallout from this situation is catastrophic.

Compliance 63

Compliance Compliance Safety Business 63

Veriheal

AUGUST 12, 2021

The authors added that in spite of the growing availability and diversity of alternative cannabinoid products like artisanal CBD—as opposed to pharmaceutical CBD—existing studies assessing their efficacy and/or safety are extremely rare. The majority of patients (74%) were Caucasian and more than half (55%) identified as female.

Epilepsy 66

Epilepsy Pharmaceutical Patients Sleep 66

The Blunt Truth

MAY 26, 2020

In his statement, Commissioner Hahn noted that the FDA was working on: 1) continuing to educate the public on the risks of CBD; 2) seeking reliable data on the safety and benefits of CBD, including opening the public docket on the matter; and 3) monitoring the marketplace for the sale and marketing of unapproved drugs.

CBD 103

CBD Hemp Programs Food 103

Miss Marijuana

JUNE 30, 2019

I mean duh, with social media, bosses that don’t understand you have a life and the new Bob Dylan documentary on Netflix – how can anyone doze off and dream anymore? And who doesn’t feel that dark cloud of stress, anxiety and drag get bigger when they’re tossing and turning all night? So what’s next?

Sleep 72

Sleep CBD Clinical Trials Oil 72

Medicinal Genomics

SEPTEMBER 27, 2018

Within this blog post, we have identified the statements included in the Analytical Cannabis article that Medicinal Genomics knows to be false, those that are true, as well as supplemental data on our position on each specific issue. This is an assumption that works well in short-form media but fails under any prolonged scientific scrutiny.

Food 69

Food Data Safety Patients 69

The Joint Blog

JULY 25, 2020

Lately, CBD has warranted a huge share of public and media attention for its perceived benefits to health and well-being. FDA is the government agency that ensures the safety and quality of foods, drugs, cosmetics, and other like products marketed in the United States. CBD Legal and Safety Issues An FDA report presented to the U.S.

CBD 33

CBD Clinical Trials Safety Media 33

SpeedWeed

MARCH 7, 2021

In the latest episode of the Cannacurio Podcast from Cannabiz Media, my co-host, Amanda Guerrero, and I discuss license updates coming to the Cannabiz Media License Database, including Oregon cannabis licenses, Louisiana CBD licenses, and Pennsylvania, Ohio, Montana and South Carolina hemp licenses. ‍ Ed Keating : Hi Amanda.

Extraction 52

Extraction Data Hemp Research and Development 52

Cannabis Law Report

JANUARY 13, 2020

Continue to explore CBDV in autism through a combination of open-label and investigator-led placebo controlled clinical trials with data from one or more of these programs in 2020. Media Enquiries: Sam Brown Inc. media enquiries. Execute NHIE clinical program utilizing an intravenous formulation of cannabidiol. Christy Curran.

Pharmaceutical 66

Pharmaceutical Clinical Trials Research and Development Programs 66

SpeedWeed

APRIL 21, 2021

Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts. Ed has managed product, marketing, and sales while overseeing complex multijurisdictional product lines in the securities, corporate, UCC, safety, environmental, and human resource markets. .

Programs 52

Programs Dispensary Oil Cultivation 52

Greenspoon Marder Cannabis Law Group Blog

APRIL 2, 2019

For example, we’re seeking comments, data and information on a variety of topics including: what levels of cannabis and cannabis-derived compounds cause safety concerns; how the mode of delivery (e.g.,

CBD 40

CBD Research and Development Safety Therapy 40

Cannabis Law Report

FEBRUARY 17, 2022

Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. Mycotoxins are contaminants that licensees are required to screen for to uphold public health, safety, and welfare. There are currently no ISO-accredited Independent Testing Laboratories located on Nantucket.

Marijuana 52

Marijuana Seed-To-Sale Safety Patients 52

Cannabis Law Report

DECEMBER 14, 2021

We are proud to leverage our proprietary IP, formulation expertise, safety surveillance and patient reported data from the U.S. Media Lindsay Wilson. media@col-care.com. to bring innovation and precision to the growing UK medical cannabis market. Investor Lee Ann Evans. Investor Relations. 1.212.271.0915. ir@col-care.com.

Extraction 52

Extraction Patients Medicine Tincture 52

SpeedWeed

JULY 30, 2021

In my review of that book for Leafly , I charged Berenson with being a fundamentally dishonest writer, willing to purposefully and consistently distort data and provide false witness so long as it bolsters his central claim that cannabis is incredibly dangerous. So if you’re asking me where to turn for the hard data, I’d say start here.

Marijuana 52

Marijuana History Data Strains 52